carnosine has been researched along with Chronic Hepatitis C in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakizaki, S; Kanda, D; Mori, M; Nagamine, T; Nakajima, H; Otsuka, T; Sato, K; Sohara, N; Suzuki, H; Takagi, H | 1 |
| Kakizaki, S; Kanda, D; Mori, M; Sato, K; Sohara, N; Suzuki, H; Takagi, H | 1 |
| Deguchi, A; Himoto, T; Hosomi, N; Kinekawa, F; Kuriyama, S; Kurokochi, K; Masaki, T; Matsuki, M; Nakai, S; Senda, S; Watanabe, S; Yachida, M | 1 |
| Kakibuchi, N; Kawakami, T; Kawashima, A; Kita, K; Koyabu, T; Murakami, Y; Okita, M; Takaguchi, K | 1 |
| Kakizaki, S; Kojima, A; Mori, M; Nagamine, T; Nakajima, K; Takagi, H; Takayama, H | 1 |
| Abe, T; Hashimoto, Y; Kakizaki, S; Kojima, A; Matsumoto, T; Mori, M; Nagamine, T; Otsuka, T; Sato, K; Sato, S; Suzuki, K; Takagi, H; Takayama, H; Takezawa, J | 1 |
5 trial(s) available for carnosine and Chronic Hepatitis C
| Article | Year |
|---|---|
Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2.
Topics: Adult; Aged; Antiviral Agents; Carnosine; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver Function Tests; Male; Middle Aged; Organometallic Compounds; Zinc Compounds | 2006 |
Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial.
Topics: Adult; Aged; Anti-Ulcer Agents; Antiviral Agents; Body Weight; Carnosine; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Organometallic Compounds; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Zinc; Zinc Compounds | 2006 |
Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Ascorbic Acid; Carnosine; Dietary Supplements; Drug Therapy, Combination; Fatty Acids, Unsaturated; Female; Flow Cytometry; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Organometallic Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thiobarbituric Acid Reactive Substances; Time Factors; Transaminases; Treatment Outcome; Vitamin E; Vitamins; Zinc; Zinc Compounds | 2007 |
Preliminary study of combination therapy with interferon-alpha and zinc in chronic hepatitis C patients with genotype 1b.
Topics: Carnosine; Circadian Rhythm; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Organometallic Compounds; Porphobilinogen Synthase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Zinc; Zinc Compounds; Zinc Sulfate | 2000 |
Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C.
Topics: Adult; Carnosine; DNA, Viral; Drug Synergism; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Logistic Models; Male; Middle Aged; Organometallic Compounds; Treatment Outcome; Viral Load; Zinc; Zinc Compounds | 2001 |
1 other study(ies) available for carnosine and Chronic Hepatitis C
| Article | Year |
|---|---|
Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Carnosine; Collagen Type IV; Copper; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hyaluronic Acid; Iron; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Organometallic Compounds; Platelet Count; Serum Albumin; Time Factors; Zinc; Zinc Compounds | 2007 |